Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients
Background: Hepatocellular carcinoma [HCC] is one of the leading causes of cancer-related deaths worldwide. A major problem with HCC surveillance is the lack of reliable biomarkers. Serum transthyretin [TTR] may be a sensitive marker for the diagnosis of patients with liver cell damage, liver cirrho...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Al-Azhar University, Faculty of Medicine (Damietta)
2020-04-01
|
Series: | International Journal of Medical Arts |
Subjects: | |
Online Access: | https://ijma.journals.ekb.eg/article_82380_37df342f1483d981733ec70d834c8af1.pdf |